Current Oncology, Volume 18, Issue 6

Lymphedema in Canada: A Qualitative Study to Help Develop a Clinical, Research, and Education Strategy [...]

AMO has participated on advisory boards for AstraZeneca, Celgene Corporation, and Sanofi–Aventis [...]

Is the age of onset of breast cancer in women with a BRCA1 or BRCA2 mutation decreasing?[...].

Cancer contributes to approximately 13% (7.4 million) of all deaths worldwide ¹, making cancer the leading cause of death across the globe. Based on Canadian data, 29% of deaths each year are estimated to be related to cancer ² [...].

Consumption of dietary carcinogens contributes to the prevalence of cancer in society [...].

In addition to chemotherapeutics, cancer patients often take a variety of medications for reasons related and unrelated to their underlying cancer [...].

Objective: Nationally, efforts to implement an innovation in cancer surgery—a Web-based synoptic reporting tool—are ongoing in five provinces. The objective of the present study was to identify the key multilevel factors influencing implementation an...

Objectives: Febrile neutropenia is considered an oncologic emergency, for which prompt initiation of antibiotics is essential. Methods: We conducted a retrospective cohort study for the 2006 calendar year involving all adult oncology patients present...

Background: Although arthralgia is a known adverse effect of aromatase inhibitor (ai) treatment in postmenopausal breast cancer patients, few studies have carried out a comprehensive evaluation of the nature, onset, and incidence of musculoskeletal (...

The inaugural Canadian Cardiac Oncology Network conference was held at the Ottawa Convention Centre, Ottawa, Ontario, May 13, 2011. The learning objectives of the meeting were to: 1. understand and appreciate the importance of cardiac toxicity in the...

The discovery of the insulin-like growth factor (igf) system occurred half a century ago, in a series of experiments showing that the growth hormone itself exercises no direct metabolic action on skeletal tissues, but rather acts through secondary su...

In recent years, significant advances have been made in the management of metastatic colorectal cancer. Traditionally, an improvement in overall survival has been considered the “gold standard”—the most convincing measure of efficacy. However, overal...

Objective: The aim of this study was to gather data from Canadian stakeholders to help construct a national strategy and agenda for lymphedema management. Methods: The Canadian Lymphedema Framework, a collaboration of medical academics, lymphedema th...

Objective: Our goal was to develop evidence-based recommendations for the organization and structure of cancer survivorship services, and best-care practices to optimize the health and well-being of post–primary treatment survivors. This review sough...

Introduction: The primary objective of this pilot study was to examine the inter-rater reliability in scoring the computed tomography (ct) imaging features of spinal metastases in patients referred for radiotherapy (rt) for bone pain. Methods: In a r...

Purpose: The adoption of a chemotherapeutic regimen in oncologic practice is a function of both its clinical and its economic impacts on cancer management. For breast cancer, U.S. Oncology trial 9735 reported significant improvements in disease-free...

Background: Systemic treatment options in hepatocellular carcinoma (hcc) are limited. Sorafenib, a multikinase inhibitor, has been shown to improve survival in patients with advanced hcc and adequate hepatic reserve. Currently, the proportion of refe...

Introduction: In non-small-cell lung cancer (nsclc), invasive mediastinal staging is typically used to guide treatment decision-making. Here, we present clinical practice guideline recommendations for invasive mediastinal staging in nsclc patients wh...